Cargando…
Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome
BACKGROUND: Bifidobacterium longum 35624 has shown efficacy in improving irritable bowel syndrome (IBS) symptoms compared with placebo in double-blind randomized studies. However, few data are available from real-life clinical practice or from studies that used Rome IV criteria to diagnose IBS. AIM:...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891724/ https://www.ncbi.nlm.nih.gov/pubmed/35317278 http://dx.doi.org/10.3748/wjg.v28.i7.732 |